The Implied Analyst 12-Month Target For FNDA
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 01 2025
0mins
Source: NASDAQ.COM
ETF Analyst Target Price Insights: The Schwab Fundamental U.S. Small Company Index ETF (FNDA) has an implied analyst target price of $33.56, indicating a potential upside of 14.89% from its current trading price of $29.21.
Notable Holdings with Upside Potential: Key underlying holdings such as IHS Holding Ltd, Axcelis Technologies Inc, and AMC Entertainment Holdings Inc show significant upside potential based on analyst targets, raising questions about the validity of these projections amidst market conditions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ACLS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ACLS
Wall Street analysts forecast ACLS stock price to fall
3 Analyst Rating
1 Buy
1 Hold
1 Sell
Hold
Current: 164.270
Low
94.00
Averages
99.67
High
105.00
Current: 164.270
Low
94.00
Averages
99.67
High
105.00
About ACLS
Axcelis Technologies, Inc. is primarily a producer of ion implantation equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The Company is focused on developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the enabling steps in the IC manufacturing process. The Company's products include High Current, Medium Energy, High Energy, Mid Current, and GSD Ovation. The Company's Purion H6 next generation high current ion implanters deliver process control by leveraging its spot beam architecture, optimized for the full spectrum of high-current applications. The Company's Purion H200 is its state-of-the-art single wafer high current medium energy implanter. Its Purion XE Series high energy ion implanters use RF Linear Accelerator (LINAC) technology. The Company's Purion M ion implanters offer the broadest spectrum of mid-current doses available.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Axcelis Technologies Benefits from Surge in Memory Demand
- Surge in Memory Demand: In Q1 2023, Axcelis shipped the highest number of ion implantation systems to the memory industry, leading to significant revenue and bookings growth, highlighting the company's critical role in the rapidly expanding AI hardware market.
- Revenue Growth Potential: Although Axcelis reported total revenue of $199 million in Q1, a mere 3% increase year-over-year, projections suggest revenue could grow over 9% to $921 million by 2027, indicating potential for stronger growth momentum ahead.
- Competitive Market Advantage: Axcelis's ion implantation machines are essential in memory chip manufacturing, particularly as demand for high-bandwidth memory surges due to AI workloads, securing its strategic position within the semiconductor industry.
- Investor Interest: Despite Axcelis's P/E ratio of 48.9, significantly higher than the S&P 500 and Nasdaq-100, long-term investors may see value in the stock over the next few years, especially as AI workloads transition from data centers to personal computers and smartphones.
See More
Axcelis Technologies Q1 2026 Earnings Call Insights
- Financial Performance Exceeds Expectations: Axcelis reported Q1 2026 revenue of $199 million and earnings per diluted share of $0.72, slightly above expectations, despite a one-time $5 million customer settlement impact, demonstrating resilience in the market.
- System Shipment Growth: While CS&I revenue moderated sequentially, it grew over 30% year-over-year, and system shipments to the memory market reached their highest level since Q4 2023, indicating strong demand in key markets.
- Optimistic Future Outlook: The company expects Q2 revenue of approximately $205 million with gross margins around 43% and estimated net earnings per diluted share of about $0.90, reflecting confidence in revenue growth in the second half, particularly in silicon carbide.
- Merger Progressing Smoothly: The merger with Veeco is anticipated to close in the second half of 2026, with the only remaining approval being regulatory clearance in China, highlighting positive strategic integration efforts.
See More
Axcelis (ACLS) Q1 2026 Earnings Call Transcript
See More
Axcelis Technologies Stock Rises 42.21% Over Month
- Stock Performance: Axcelis Technologies (ACLS) closed at $143.13, reflecting a 2.34% increase from the previous day, outperforming the S&P 500's daily gain of 0.8%, indicating strong performance in the semiconductor services sector.
- Monthly Gain: Over the past month, Axcelis's stock has surged by 42.21%, significantly exceeding the Computer and Technology sector's gain of 12.05% and the S&P 500's 8.11%, reflecting optimistic market expectations for its future growth.
- Earnings Expectations: Axcelis is set to release its earnings report on May 7, 2026, with projected earnings per share (EPS) of $0.71, a 31.73% decrease year-over-year, but quarterly revenue is expected to reach $195.05 million, up 1.29%, indicating potential revenue growth.
- Valuation Analysis: Currently, Axcelis trades at a forward P/E ratio of 39.51, below the industry average of 40.35, suggesting its stock may be undervalued, while a PEG ratio of 13.48 indicates high expectations for future earnings growth, warranting investor attention to its industry ranking and market performance.
See More
AXCELIS TECHNOLOGIES INC: B. RILEY UPGRADES TO BUY FROM NEUTRAL AND INCREASES TARGET PRICE TO $150 FROM $91
Company Acquisition: Acelist Technologies is set to acquire Neutral, indicating a strategic move in the tech industry.
Target Price Increase: Acelist has raised its target price to $150 from $91, reflecting increased confidence in its market position.
See More
Axcelis to Present Keynote at CS Asia Conference
- Conference Sponsorship: Axcelis Technologies announced its role as the Diamond Sponsor for the 2026 Compound Semiconductor Asia Conference, taking place from March 24-27 in Shanghai, which reinforces its leadership position in the semiconductor industry and enhances its market influence.
- CEO Keynote Speech: President and CEO Russell Low, PhD, will deliver the opening keynote speech at the conference, sharing insights on the company's innovations in ion implantation solutions, which is expected to attract significant attention from industry participants and elevate the company's brand recognition.
- Technology Innovation Showcase: The company will also introduce its next-generation Purion Power Series+ platform, aimed at meeting the demands of Chinese chipmakers for high-performance semiconductor solutions, thereby driving the global demand for clean energy solutions.
- Industry Leadership: With over 45 years of experience in ion implantation systems, Axcelis is dedicated to providing high-productivity solutions for the semiconductor industry, further solidifying its position as an innovator and leader in the global market.
See More
Axcelis Technologies Benefits from Surge in Memory Demand
- Surge in Memory Demand: In Q1 2023, Axcelis shipped the highest number of ion implantation systems to the memory industry, leading to significant revenue and bookings growth, highlighting the company's critical role in the rapidly expanding AI hardware market.
- Revenue Growth Potential: Although Axcelis reported total revenue of $199 million in Q1, a mere 3% increase year-over-year, projections suggest revenue could grow over 9% to $921 million by 2027, indicating potential for stronger growth momentum ahead.
- Competitive Market Advantage: Axcelis's ion implantation machines are essential in memory chip manufacturing, particularly as demand for high-bandwidth memory surges due to AI workloads, securing its strategic position within the semiconductor industry.
- Investor Interest: Despite Axcelis's P/E ratio of 48.9, significantly higher than the S&P 500 and Nasdaq-100, long-term investors may see value in the stock over the next few years, especially as AI workloads transition from data centers to personal computers and smartphones.
See More
Axcelis Technologies Q1 2026 Earnings Call Insights
- Financial Performance Exceeds Expectations: Axcelis reported Q1 2026 revenue of $199 million and earnings per diluted share of $0.72, slightly above expectations, despite a one-time $5 million customer settlement impact, demonstrating resilience in the market.
- System Shipment Growth: While CS&I revenue moderated sequentially, it grew over 30% year-over-year, and system shipments to the memory market reached their highest level since Q4 2023, indicating strong demand in key markets.
- Optimistic Future Outlook: The company expects Q2 revenue of approximately $205 million with gross margins around 43% and estimated net earnings per diluted share of about $0.90, reflecting confidence in revenue growth in the second half, particularly in silicon carbide.
- Merger Progressing Smoothly: The merger with Veeco is anticipated to close in the second half of 2026, with the only remaining approval being regulatory clearance in China, highlighting positive strategic integration efforts.
See More
Axcelis (ACLS) Q1 2026 Earnings Call Transcript
See More
Axcelis Technologies Stock Rises 42.21% Over Month
- Stock Performance: Axcelis Technologies (ACLS) closed at $143.13, reflecting a 2.34% increase from the previous day, outperforming the S&P 500's daily gain of 0.8%, indicating strong performance in the semiconductor services sector.
- Monthly Gain: Over the past month, Axcelis's stock has surged by 42.21%, significantly exceeding the Computer and Technology sector's gain of 12.05% and the S&P 500's 8.11%, reflecting optimistic market expectations for its future growth.
- Earnings Expectations: Axcelis is set to release its earnings report on May 7, 2026, with projected earnings per share (EPS) of $0.71, a 31.73% decrease year-over-year, but quarterly revenue is expected to reach $195.05 million, up 1.29%, indicating potential revenue growth.
- Valuation Analysis: Currently, Axcelis trades at a forward P/E ratio of 39.51, below the industry average of 40.35, suggesting its stock may be undervalued, while a PEG ratio of 13.48 indicates high expectations for future earnings growth, warranting investor attention to its industry ranking and market performance.
See More
AXCELIS TECHNOLOGIES INC: B. RILEY UPGRADES TO BUY FROM NEUTRAL AND INCREASES TARGET PRICE TO $150 FROM $91
Company Acquisition: Acelist Technologies is set to acquire Neutral, indicating a strategic move in the tech industry.
Target Price Increase: Acelist has raised its target price to $150 from $91, reflecting increased confidence in its market position.
See More
Axcelis to Present Keynote at CS Asia Conference
- Conference Sponsorship: Axcelis Technologies announced its role as the Diamond Sponsor for the 2026 Compound Semiconductor Asia Conference, taking place from March 24-27 in Shanghai, which reinforces its leadership position in the semiconductor industry and enhances its market influence.
- CEO Keynote Speech: President and CEO Russell Low, PhD, will deliver the opening keynote speech at the conference, sharing insights on the company's innovations in ion implantation solutions, which is expected to attract significant attention from industry participants and elevate the company's brand recognition.
- Technology Innovation Showcase: The company will also introduce its next-generation Purion Power Series+ platform, aimed at meeting the demands of Chinese chipmakers for high-performance semiconductor solutions, thereby driving the global demand for clean energy solutions.
- Industry Leadership: With over 45 years of experience in ion implantation systems, Axcelis is dedicated to providing high-productivity solutions for the semiconductor industry, further solidifying its position as an innovator and leader in the global market.
See More
